| Case Number |
Title |
Non-Confidential Summary |
Issued Patent |
Lead Inventor's Website |
| BAS_REN.005
|
Cell Lines which Constitutively Express IGF-1 and IGF-1 R
|
|
[US Patent No. 5,262,308]
|
Link
|
| BEN_JEF.003
|
Compositions And Methods For Modulating The Activity Of G Protein-Kinases
|
|
[US Patent No. 6,255,069]
|
Link
|
| BER_WOL.001
|
CalDAG-GEFI Inhibitors as Anti-Platelet Drugs
|
NCS for BER_WOL.001 |
|
|
| BLO_TIM.002
|
Glucosidase Inhibitors as a Treatment for Viruses that Bud from the Endoplasmic Reticulum
|
|
|
|
| CHU_MON.001
|
Fibulin-2 Null Mutant Mice
|
|
|
Link
|
| CRO_CAR.002
|
Compositions, Kits and Methods Relating to the Human FEZ1 Gene, a Novel Tumor Suppressor Gene
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
|
|
| CRO_CAR.004
|
The Human FHIT Gene
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
[United States Patent: 7220834]
[United States Patent: 6774217]
[United States Patent: 6242212]
[United States Patent: 5928884]
|
|
| CRO_CAR.009
|
TCL-1 Gene And Protein And Related Methods And Compositions
|
NCS for Croce TCL-1 techs (CRO 9,15) |
|
|
| CRO_CAR.015
|
Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression
|
NCS for Croce TCL-1 techs (CRO 9,15) |
|
|
| CRO_CAR.016
|
Novel Tumor Suppressor Gene and Compositions and Methods for Making and Using the Same
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
|
|
| CRO_CAR.017
|
Role of microRNA Genes In Human Cancer
|
NCS for Croce miRNA techs (CRO 17, 25) |
|
|
| CRO_CAR.019
|
Involvement Of The ALL-1 Gene In A Solid Tumor1
|
|
[US Patent No. 5,567,586]
|
|
| CRO_CAR.025
|
microRNA genes in cancer diagnosis and treatment
|
NCS for Croce miRNA techs (CRO 17, 25) |
|
|
| DAN_REN.001
|
Inhibition of HIV-1 replication in human peripheral blood monocytes through a clinically used drug
|
|
|
Link
|
| DAN_REN.005
|
Methods to Measure Frequency of Integration in the Vicinity of Active Genes
|
|
|
Link
|
| HOU_YAM.005
|
Apoptosis of Cardiomyocytes
|
|
|
Link
|
| HOU_YAM.006
|
Antibiotics Targeting a Growth-Dependent Bacterial Enzyme
|
|
|
Link
|
| IAC_LOR.001
|
A Human Model System For In Vitro Development Of The Dopaminergic Phenotype
|
NCS for IAC_LOR.001 |
[US Patent No. 7,195,910]
|
Link
|
| IOZ_REN.001
|
A Role For Decorin In Tumor Suppression
|
|
[US Patent No. 6,524,573]
|
Link
|
| KHI_JAS.001
|
Humanized Cartilage in Mouse
|
|
[US Patent No. 6,448,470]
|
|
| KMI_ERI.005
|
Methods for Enhancing Gene Conversion or Genetic Repair by Chimeric Oligonucleotides
|
|
|
|
| KOC_WAL.005
|
Adrenal Beta-Arrestin 1 is a Critical Regulator of Post-Myocardial Infarction Aldosterone Levels During Progression to Heart Failure
|
|
|
Link
|
| KOP_HIL.006
|
Polypeptides Fused with Alfalfa Mosaic Virus or Ilarvirus Capsid Proteins
|
|
[US Patent No. 6,042,832]
[US Patent No. 6,448,070]
|
Link
|
| LIS_MIC.008
|
Autophagy in the Tumor Stroma: Is Cancer Eating Us Alive?
|
|
|
Link
|
| NEV_MAR.001
|
Establishment of a New Human Androgen-Dependent Prostate Cancer Cell Line that is Tumorigenic in Nude Mice
|
NCS for NEV_MAR.001 |
|
Link
|
| NEV_MAR.005
|
A Pharmacological Inhibitor of Stat5a/b: IST5
|
|
|
Link
|
| OSH_MIC.001
|
Chronic Recurring Migraine Headache Model in Rodents
|
|
|
Link
|
| OSH_MIC.002
|
Inherited Rat Headache Model
|
|
|
Link
|
| PASC_JOH.001
|
Crystal Structure of the Active Conformation of PARP-1 and Novel Binding Pockets for Inhibitor Design
|
|
|
|
| PIT_GIO.001
|
Three Novel Molecular Biomarkers for Colorectal Cancer Diagnosis and Treatment
|
NCS for PIT_GIO.001 |
|
|
| RAB_JOS.001
|
Development of an Enhancer/Promoter Pair for Heart Selective Gene Expression
|
NCS for RAB_JOS.001 |
|
Link
|
| SCH_JAY.008
|
Treatment of Parkinson's Disease and Parkinson's Disease Treatment-related Complications with RNA Inhibition Therapies
|
NCS for SCH_JAY.001, 002, 004, 008 |
|
Link
|
| SHI_YI.008
|
Prevention and Treatment of Metabolic Disorder-Associated Osteopenia/Osteoporosis and Bone Marrow Abnormalities
|
|
|
|
| SHI_YI.010
|
Prevention and Treatment of Vascular Dementia and Alzheimer's Disease
|
|
|
|
| SYK_YUR.004
|
Invention of a Novel Serum Free Media for Cultivation of Hybridoma Cells to Achieve Production of Highly Homogenous Monoclonal Antibodies (MAb) in Preparative Scale
|
NCS for SYK_YUR.004 |
|
Link
|
| TAR_THE.005
|
Malaria Drug Resistance is Associated with DNA Mismatch Repair Deficiency
|
NCS for TAR_THE.005 |
|
|
| THO_JEF.001
|
Nitric Oxide Donor Compositions, Methods, Apparatus, and Kits for Alleviating Vasoconstriction and Vasospasm in a Mammal
|
|
[US Patent No. 6,358,536]
|
|
| WIC_ERI.002
|
Peptide Nucleic Acid Conjugates
|
|
[US Patent No. 6,180,767]
|
Link
|
| WIL_KEV.001
|
Human Genomic Clone Encoding Human Chondroitin 6-Sulfotransferase
|
|
[US Patent No. 6,399,358]
|
|
| ZIT_NIC.001
|
Long Chain N-Alkyl Compounds and Oxa-Derivatives Thereof
|
|
|
|
